An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced br ...

In the future, delivering therapeutic drugs exactly where they are needed within the body could be the task of miniature ...

Researchers have taken a major step toward developing a revolutionary approach that could transform how we fight cancer.

Interestingly, these flower-shaped particles have a diameter ranging from 1 to 5 micrometers. This size makes them slightly ...

But Koffman, after relapsing or refracting from targeted therapies, immunotherapies ... antibodies that can grab onto cancer ...

Rigakembio and NextCure launch phase 1 trial of targeted ADC cancer drug in U.S. New collaboration marks a significant step ...

The initiation of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs), particularly rituximab ...

While other big pharmas have faltered, Lilly made headway in a Phase 3 trial that could provide a treatment option to replace ...

Avacta Group plc ( (GB:AVCT) ) has shared an announcement.

More about Repare Therapeutics Repare Therapeutics is a clinical-stage precision oncology company focused on discovering and developing targeted cancer therapies using its proprietary synthetic ...

Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities. Heterogeneity and drug resistance among tumors pose a serious challenge ...